$AGE 90 DAYS STOCK PRICE FORECAST
Stock Price
About the Company
AgeX Therapeutics, Inc. iis focused on developing and commercializing innovative therapeutics for human aging. Its PureStem® and UniverCyte™ manufacturing and immunotolerance technologies are designed to work together to generate highly-defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeX's revolutionary longevity platform induced Tissue Regeneration (iTR™) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AgeX is developing its core product pipeline for use in the clinic to extend human healthspan and is seeking opportunities to establish licensing and collaboration agreements around its broad IP estate and proprietary technology platforms.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
9
Similar Companies
| Name | Ticker | Market Capitalization (USD M) | Revenue (USD M) | Price/Book | Price/Earning | Net Margin (%) |
|---|---|---|---|---|---|---|
| Charles River Laboratories Int | CRL | 21115 | 3273 | 9.00 | 53.28 | 12.10 |
| Exact Sciences Corp. | EXAS | 15524 | 1712 | 4.63 | -17.52 | -49.89 |
| PRA Health Sciences Inc | PRAH | 10739 | 3333 | 6.88 | 50.52 | 6.40 |
| Syneos Health Inc | SYNH | 9147 | 4730 | 2.78 | 38.89 | 4.99 |
| Medpace Holdings Inc | MEDP | 7055 | 1028 | 7.81 | 40.02 | 17.02 |
| Exelixis Inc | EXEL | 6902 | 1157 | 3.31 | 74.14 | 8.13 |
| Twist Bioscience Corp | TWST | 5634 | 127 | 9.68 | -42.81 | -106.59 |
| Allakos Inc | ALLK | 5438 | 9.89 | -27.30 | None | |
| Vir Biotechnology Inc | VIR | 5162 | 183 | 7.14 | -17.02 | -162.74 |
| Sana Biotechnology Inc | SANA | 3669 | 4.21 | -11.20 | None | |
| Recursion Pharmaceuticals Inc | RXRX | 3242 | 9 | 5.07 | -26.44 | None |
| Lyell Immunopharma Inc | LYEL | 3126 | 8 | 3.06 | -16.15 | None |
| Instil Bio Inc | TIL | 2312 | 0 | 3.63 | -28.00 | None |
| Alx Oncology Holdings Inc | ALXO | 2166 | 1 | 5.39 | -18.67 | -401.23 |
| Verve Therapeutics Inc | VERV | 2083 | 5.13 | -21.06 | None | |
| Allogene Therapeutics Inc | ALLO | 2062 | 38 | 2.19 | -8.60 | -621.84 |
| Erasca Inc | ERAS | 2055 | -14.41 | -16.25 | None | |
| Sorrento Therapeutics Inc | SRNE | 1840 | 51 | 11.05 | -5.81 | -626.43 |
| Cortexyme Inc | CRTX | 1710 | 11.90 | -19.39 | None | |
| Constellation Pharmaceuticals | CNST | 1564 | 4.32 | -11.18 | None | |
| Castle Biosciences Inc | CSTL | 1554 | 78 | 4.09 | -66.91 | -28.88 |
| Pandion Therapeutics Inc | PAND | 1501 | 1069 | 1.83 | -13.34 | -10.55 |
| AlloVir Inc | ALVR | 1480 | 0 | 5.06 | -12.56 | -718.59 |
| Replimune Group Inc | REPL | 1458 | 2.91 | -16.17 | None | |
| Organogenesis Holdings Inc | ORGO | 1372 | 433 | 7.83 | 18.15 | 16.17 |
| Rubius Therapeutics Inc | RUBY | 1330 | 5.45 | -7.67 | None | |
| Y-Mabs Therapeutics Inc | YMAB | 1138 | 37 | 4.92 | -24.73 | -114.04 |
| National Research Corp | NRC | 1129 | 140 | 14.47 | 31.01 | 25.62 |
| Caribou Biosciences Inc | CRBU | 1098 | 5 | -24.96 | -21.71 | -955.31 |
| Century Therapeutics Inc | IPSC | 1076 | 2.42 | -15.44 | None | |
| Monte Rosa Therapeutics Inc | GLUE | 1016 | 2.94 | -17.64 | None | |
| Cullinan Oncology Inc | CGEM | 946 | 19 | 2.06 | -17.35 | -284.59 |
| Scholar Rock Holding Corp | SRRK | 901 | 16 | 4.21 | -8.33 | -687.82 |
| Precigen Inc | PGEN | 898 | 101 | 6.34 | -8.13 | -107.45 |
| Janux Therapeutics Inc | JANX | 882 | 1 | 2.33 | -76.82 | -436.67 |
| RAPT Therapeutics Inc | RAPT | 803 | 5 | 4.35 | -13.37 | 7.14 |
| Sutro Biopharma Inc | STRO | 792 | 69 | 2.83 | -8.69 | -114.69 |
| Imago BioSciences Inc | IMGO | 776 | -9.97 | -29.79 | None | |
| Design Therapeutics Inc | DSGN | 765 | 0 | 1.91 | -39.74 | -245.44 |
| MeiraGTx Holdings plc | MGTX | 723 | 19 | 3.80 | -12.51 | -325.95 |
| Graphite Bio Inc | GRPH | 718 | 1.96 | -14.58 | None | |
| Ideaya Biosciences Inc | IDYA | 709 | 36 | 3.65 | -27.21 | -84.49 |
| Crinetics Pharmaceuticals Inc | CRNX | 693 | 0 | 3.99 | -7.81 | -447.78 |
| Talaris Therapeutics Inc | TALS | 646 | 2.43 | -18.98 | None | |
| Precision Biosciences Inc | DTIL | 556 | 101 | 5.88 | -11.16 | -45.88 |
| Vor Biopharma Inc | VOR | 546 | 2.19 | -8.34 | None | |
| Acumen Pharmaceuticals Inc | ABOS | 541 | 1 | -5.30 | -5.57 | -550.91 |
| Rallybio Corp | RLYB | 526 | 38 | -7.86 | -12.39 | -1.07 |
| Mirum Pharmaceuticals Inc | MIRM | 463 | 11 | 5.26 | -3.04 | None |
| Werewolf Therapeutics Inc | HOWL | 457 | 2.47 | -2.45 | None | |
| Kezar Life Sciences Inc | KZR | 449 | 3.26 | -9.36 | None | |
| Applied Therapeutics Inc | APLT | 430 | 14 | 3.84 | -3.77 | -19.41 |
| Evelo Biosciences Inc | EVLO | 401 | 7.05 | -3.79 | None | |
| Cue Biopharma Inc | CUE | 367 | 5 | 5.30 | -8.50 | -802.84 |
| Oyster Point Pharma Inc | OYST | 360 | 2.38 | -4.51 | None | |
| Vera Therapeutics Inc | VERA | 355 | 3.91 | -6.48 | None | |
| Biomea Fusion Inc | BMEA | 340 | 1.68 | -18.06 | None | |
| Sera Prognostics Inc | SERA | 335 | 0 | -2.33 | -14.21 | None |
| Surface Oncology Inc | SURF | 329 | 90 | 2.35 | 14.71 | 18.99 |
| Aerovate Therapeutics Inc | AVTE | 328 | -16.22 | -22.30 | None | |
| Magenta Therapeutics Inc | MGTA | 325 | 1.88 | -4.68 | None | |
| Cabaletta Bio Inc | CABA | 312 | 3.20 | -8.02 | None | |
| Luna Innovations Inc | LUNA | 299 | 101 | 3.70 | 129.57 | 2.46 |
| Black Diamond Therapeutics Inc | BDTX | 284 | 1.14 | -2.71 | None | |
| INmune Bio Inc | INMB | 256 | 0 | 7.54 | -13.13 | None |
| Pieris Pharmaceuticals Inc | PIRS | 253 | 24 | 6.35 | -5.23 | -203.73 |
| Compass Therapeutics Inc | CMPX | 253 | 8.68 | -3.11 | None | |
| Candel Therapeutics Inc | CADL | 247 | 0 | -6.58 | -7.10 | None |
| Nextcure Inc | NXTC | 241 | 22 | 0.90 | -3.56 | -163.57 |
| Sensei Biotherapeutics Inc | SNSE | 218 | 1.32 | -7.63 | None | |
| AquaBounty Technologies Inc | AQB | 216 | 0 | 1.23 | -10.59 | None |
| Gemini Therapeutics Inc | GMTX | 211 | 1088 | 0.23 | 1.74 | 11.24 |
| Alzamend Neuro Inc | ALZN | 197 | 12.61 | -32.43 | None | |
| Impel NeuroPharma Inc. | IMPL | 182 | 3.65 | -3.76 | None | |
| Elevation Oncology Inc | ELEV | 179 | 1.16 | -8.02 | None | |
| Tscan Therapeutics Inc | TCRX | 174 | 6 | -2.90 | -5.07 | -563.14 |
| Hookipa Pharma Inc | HOOK | 152 | 20 | 1.20 | -2.48 | -304.07 |
| Reneo Pharmaceuticals Inc | RPHM | 151 | 0.92 | -5.54 | None | |
| Unity Biotechnology Inc | UBX | 124 | 1 | 1.93 | -1.53 | None |
| IN8bio Inc | INAB | 112 | -5.24 | -11.17 | None | |
| HCW Biologics Inc | HCWB | 109 | 4 | -4.95 | -16.95 | -162.03 |
| Exicure Inc | XCUR | 104 | 4 | 2.81 | -2.19 | -148.49 |
| Axcella Health Inc | AXLA | 103 | 2700 | 2.21 | -1.84 | -10.84 |
| Cyclerion Therapeutics Inc | CYCN | 90 | 4 | 1.76 | -1.34 | None |
| BioVie Inc | BIVI | 72 | 29.90 | -0.40 | None | |
| Scopus Biopharma Inc | SCPS | 70 | 234 | -35.55 | -3.34 | 80.93 |
| Eloxx Pharmaceuticals Inc | ELOX | 70 | 0 | 3.17 | -1.28 | -14.14 |
| Synaptogenix Inc | SNPX | 65 | 2.05 | -4.31 | None | |
| Monopar Therapeutics Inc | MNPR | 60 | 2.68 | -7.56 | None | |
| NanoViricides Inc | NNVC | 54 | 1.88 | -6.05 | None | |
| CohBar Inc | CWBR | 53 | 4.84 | -3.17 | None | |
| Rezolute Inc | RZLT | 53 | 3.91 | -2.43 | None | |
| Acurx Pharmaceuticals Inc | ACXP | 48 | 3.14 | -6.00 | None | |
| Vaccinex Inc | VCNX | 47 | 1 | 3.53 | -1.66 | -48.71 |
| Cyclo Therapeutics Inc | CYTH | 39 | 1 | 3.77 | -1.86 | -989.80 |
| TransCode Therapeutics Inc | RNAZ | 38 | -8.08 | -10.86 | None | |
| Unicycive Therapeutics Inc | UNCY | 36 | 113 | -8.79 | -9.81 | 7.94 |
| AgeX Therapeutics Inc | AGE | 35 | 2 | -4.18 | -3.68 | -522.77 |
| Aridis Pharmaceuticals Inc | ARDS | 35 | 0 | -3.79 | -1.40 | -851.00 |
| Cytocom Inc | CBLI | 30 | 0 | 3.88 | -12.72 | -912.16 |
| Tenax Therapeutics Inc | TENX | 18 | 0 | 27.83 | -0.71 | -840.64 |
| Geovax Labs Inc | GOVX | 16 | 1 | 1.30 | -11.11 | -558.09 |
| Kiromic BioPharma Inc | KRBP | 15 | 6.91 | -1.10 | None | |
| Xenetic Biosciences Inc | XBIO | 14 | 1 | 1.73 | -1.07 | -47.40 |
| Neurotrope Inc | NTRP | 5 | 29 | 0.08 | 0.76 | 23.48 |
AGE.A - AgeX Therapeutics Inc Profile | Reuters
AgeX Therapeutics Inc. is a biotechnology company. The Company is focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Its product ...
AgeX Therapeutics Inc. Shares Near 52-Week Low - Market Mover
AgeX Therapeutics Inc. (AGE) shares closed today at 0.4% above its 52 week low of $0.90, giving the company a market cap of $34M. The stock is currently down 39.3% year-to-date, up 9.2% over the ...
Biohaven Pharmaceutical Holding Co. Ltd.
1 Day BHVN -1.10% DJIA 1.56% S&P 500 1.71% Health Care/Life Sciences 0.66% Vladimir Coric Chief Executive Officer & Director Vita Therapeutics, Inc., Our Lady of Mercy Academy, Pyramid Biosciences ...
BRITISH & AMERICAN INVESTMENT TRUST PLC - Half-year Report
This total return outperformance was a function of both an increase of almost 50 percent in the price of our US investment Lineage Cell Therapeutics Inc (previously Biotime Inc) and the payment of ...
AgeX Therapeutics Inc AGE
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
AgeX Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
AgeX Therapeutics, Inc. Common Stock (AGE)
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
AgeX Therapeutics Inc (AGE)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
AgeX Therapeutics, Inc. (AGE)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
AgeX Therapeutics, Inc. (AGE)
U.S. employers added 235,000 jobs (+733,000 expected), unemployment rate fell to 5.2% (5.4% expected) ...